Akèy › Amiloidoz › Ohio › Cleveland
Etid klinik pou Amiloidoz nan Cleveland, OH
5 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Ap rekriteFaz 3
- Clinical Trial Site, Cleveland
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Ap rekriteEtid obsèvasyon
- Cleveland Clinic, Cleveland
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Ap rekriteFaz 1/2
- Research Site, Cleveland
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
Etid Amiloidoz nan lòt vil
- Boston, MA11 etid
- Rochester, MN10 etid
- New York City, NY10 etid
- Dallas, TX9 etid
- Philadelphia, PA7 etid
- Houston, TX6 etid
- Baltimore, MD6 etid
- Durham, NC6 etid
- Portland, OR6 etid
- St. Louis, MO6 etid
- San Diego, CA5 etid
- Chicago, IL5 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.